The differential expression of TGF-β1, ILK and wnt signaling inducing epithelial to mesenchymal transition in human renal fibrogenesis: An immunohistochemical study

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 9, 2013, Pages 1747-1758

  Kim, Min Kyung ^a   Maeng, Young In ^a   Sung, Woo Jung ^a   Oh, Hoon Kyu ^a   Park, Jae Bok ^a   Yoon, Ghil Suk ^b   Cho, Chang Ho ^a   Park, Kwan Kyu ^a  

^a Catholic University of Daegu   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

EMT; Immunohistochemistry; Integrin; Renal fibrosis; TGF beta Smad signaling; Wnt signaling

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; CADHERIN; CDH1 PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; INTEGRIN; INTEGRIN LINKED KINASE; INTEGRIN-LINKED KINASE; PROTEIN SERINE THREONINE KINASE; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA1; WNT PROTEIN; WNT5B PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; EMT; ENZYMOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FIBROSIS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY TUBULE; MALE; MIDDLE AGED; PATHOLOGY; PHENOTYPE; PHOSPHORYLATION; TGF-BETA/SMAD SIGNALING; VERY ELDERLY; WNT SIGNALING; WNT SIGNALING PATHWAY; YOUNG ADULT;

EMT; IMMUNOHISTOCHEMISTRY; INTEGRIN; RENAL FIBROSIS; TGF-BETA/SMAD SIGNALING; WNT SIGNALING;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; BIOLOGICAL MARKERS; CADHERINS; CASE-CONTROL STUDIES; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; KIDNEY TUBULES; MALE; MIDDLE AGED; PHENOTYPE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; WNT PROTEINS; WNT SIGNALING PATHWAY; YOUNG ADULT;

EID: 84885453291     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290-301.
2. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE and Neilson EG. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995; 130: 393-405.
3. Iwano M, Plieth D, Danoff TM, Xue C, Okada H and Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350.
4. Jinde K, Nikolic-Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC and Lan HY. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 2001; 38: 761-769.
5. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, Strutz F, Muller GA, Colasanti G and D'Amico G. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002; 62: 137-146.
6. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21: 212-222.
7. Quaggin SE and Kapus A. Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney Int 2011; 80: 41-50.
8. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15: 1-12.
9. Zeisberg M and Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119: 1429-1437.
10. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M and Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 2009; 119: 1438-1449.
11. Kalluri R and Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
12. Yeh YC, Wei WC, Wang YK, Lin SC, Sung JM and Tang MJ. Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Am J Pathol 2010; 177: 1743-1754.
13. Phanish MK, Wahab NA, Colville-Nash P, Hendry BM and Dockrell ME. The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochem J 2006; 393: 601-607.
14. Bhowmick NA, Zent R, Ghiassi M, McDonnell M and Moses HL. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38 MAPK and epithelial plasticity. J Biol Chem 2001; 276: 46707-46713.
15. Thornton TM, Pedraza-Alva G, Deng B, Wood CD, Aronshtam A, Clements JL, Sabio G, Davis RJ, Matthews DE, Doble B and Rincon M. Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 2008; 320: 667-670.
16. Docherty NG, O'Sullivan OE, Healy DA, Murphy M, O'Neill AJ, Fitzpatrick JM and Watson RW. TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. Am J Physiol Renal Physiol 2006; 290: F1202-1212.
17. Li Y, Yang J, Dai C, Wu C and Liu Y. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 2003; 112: 503-516.
18. Kim K, Lu Z and Hay ED. Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 2002; 26: 463-476.
19. Huang H and He X. Wnt/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol 2008; 20: 119-125.
20. Hwang I, Seo EY and Ha H. Wnt/beta-catenin signaling: a novel target for therapeutic intervention of fibrotic kidney disease. Arch Pharm Res 2009; 32: 1653-1662.
21. Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ, Messing EM, Miller SD, Peterson AC, Turk TM and Weitzel W. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 2012; 188: 2473-2481.
22. Dieter RS. Sterile pyuria: a differential diagnosis. Compr Ther 2000; 26: 150-152.
23. Kalluri R and Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-1784.
24. Zavadil J and Bottinger EP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005; 24: 5764-5774.
25. Zeisberg M and Duffield JS. Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 2010; 21: 1247-1253.
26. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M and Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008; 19: 2282-2287.
27. Li Y, Kang YS, Dai C, Kiss LP, Wen X and Liu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 2008; 172: 299-308.
28. Yang J and Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001; 159: 1465-1475.
29. Chea SW and Lee KB. TGF-beta mediated epithelial-mesenchymal transition in autosomal dominant polycystic kidney disease. Yonsei Med J 2009; 50: 105-111.
30. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN and Larue L. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 2003; 63: 2172-2178.
31. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I and Nieto MA. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 2004; 18: 1131-1143.
32. He W, Dai C, Li Y, Zeng G, Monga SP and Liu Y. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 2009; 20: 765-776.